Current trials in DMD
The table below lists all DMD trials registered or updated on clinicaltrials.gov in the last 1000 days. Because it links directly to clinicaltrials.gov it is automatically updated whenever the information on clinicaltrials.gov changes.
Please note that TREAT-NMD can take no responsibility for the accuracy of the information below, which is pulled directly from clinicaltrials.gov.
Trials for DMD listed on clinicaltrials.gov
- Study of Fordadistrogene Movaparvovec in Early Stage Duchenne Muscular Dystrophy
- Determine the Safety and Dose of EN001 in Patients With Duchenne Muscular Dystrophy(DMD)
- Telerehabilitation in Duchenne Muscular Dystrophy
- Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy
- Effects of Low-level Mechanical Vibration on Bone Density in Ambulant Children Affected by Duchenne Muscular Dystrophy
- Assessment of Neurodevelopmental Needs in Duchenne Muscular Dystrophy
- Reliability and Validity of the Turkish Version of the Upper Limb Short Questionnaire in Duchenne Muscular Dystrophy
- Defining Endpoints in Becker Muscular Dystrophy
- Correlation Between Functional Capacity and Functional Capability in Duchenne Muscular Dystrophy
- Development of a New Instrument to Evaluate Gait Characteristics of Individuals With Duchenne Muscular Dystrophy
- Effects of Parental Influence on Physical Activity Level and Participation in Children With Duchenne Muscular Dystrophy
- Tadalafil as Adjuvant Therapy for DMD
- A Study to Assess Vamorolone in Boys Ages 2 to <4 Years and 7 to <18 Years With Duchenne Muscular Dystrophy (DMD)
- A Study to Assess Vamorolone in Boys Ages 2 to <4 Years and 7 to <18 Years With Duchenne Muscular Dystrophy (DMD)
- A Study to Assess Vamorolone in Boys Ages 2 to <4 Years and 7 to <18 Years With Duchenne Muscular Dystrophy (DMD)
- A Study to Assess Vamorolone in Boys Ages 2 to <4 Years and 7 to <18 Years With Duchenne Muscular Dystrophy (DMD)
- A Study to Assess Vamorolone in Boys Ages 2 to <4 Years and 7 to <18 Years With Duchenne Muscular Dystrophy (DMD)
- A Study to Assess Vamorolone in Boys Ages 2 to <4 Years and 7 to <18 Years With Duchenne Muscular Dystrophy (DMD)
- A Study to Assess Vamorolone in Boys Ages 2 to <4 Years and 7 to <18 Years With Duchenne Muscular Dystrophy (DMD)
- A Study to Assess Vamorolone in Becker Muscular Dystrophy (BMD)